OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma
Jun W. Kim, César Márquez, Kaja Kostyrko, et al.
Nature Medicine (2019) Vol. 25, Iss. 11, pp. 1783-1795
Open Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

Low‐fat dairy consumption and the risk of lung cancer: A large prospective cohort study
Zhiyong Zhu, Linglong Peng, He Zhou, et al.
Cancer Medicine (2023) Vol. 12, Iss. 15, pp. 16558-16569
Open Access | Times Cited: 4

Integrated analysis of bulk and single-cell RNA-seq reveals the role of MYC signaling in lung adenocarcinoma
Lu Hao, Qiuyan Chen, Xi Chen, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 7

Renal clear cell carcinoma-derived CXCL5 drives tumor-associated fibroblast formation and facilitates cancer progression
Yang Liu, Hongchen Qu, Yan Huang
Pathology - Research and Practice (2023) Vol. 244, pp. 154319-154319
Open Access | Times Cited: 3

Bromodomain-containing protein 4 activates cardiotrophin-like cytokine factor 1, an unfavorable prognostic biomarker, and promotes glioblastoma in vitro
Shang-Hang Shen, Guo JianFeng, Ju Huang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 8, pp. 475-475
Open Access | Times Cited: 6

A combined aging and immune prognostic signature predict prognosis and responsiveness to immunotherapy in melanoma
Wenchang Lv, Yuanyuan Zhan, Yufang Tan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6

Ceramide synthases: insights into the expression and prognosis of lung cancer
Hui-jiang Qian, Jingjing Deng, Chao Lu, et al.
Experimental Lung Research (2020) Vol. 47, Iss. 1, pp. 37-53
Closed Access | Times Cited: 8

CNTF induces Clcf1 in astrocytes to promote the differentiation of oligodendrocyte precursor cells
Jiwei Song, Liu Zi-ying, Tao Xiang, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 636, pp. 170-177
Closed Access | Times Cited: 5

A five-gene expression signature of centromeric proteins with prognostic value in lung adenocarcinoma
Yangwei Wang, Jiaping Chen, Wangyang Meng, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 2, pp. 273-286
Open Access | Times Cited: 2

Integrated Bulk and Single-cell RNA Sequencing Data Constructs and Validates a Prognostic Model for Non-small Cell Lung Cancer
Junkai Zhu, Junluo Yang, Xinyi Chen, et al.
Journal of Cancer (2024) Vol. 15, Iss. 3, pp. 796-808
Open Access

A New Strategy to Authenticate Prognosis and Tumor Immunity Model Based on Cancer-Associated Fibroblasts lncRNA in Bladder Cancer
Hui Zhang, Hui Zhang, Yong Lu, et al.
Journal of Biomedical Nanotechnology (2024) Vol. 20, Iss. 7, pp. 1169-1186
Closed Access

Cell-cell crosstalk between fat cells and immune cells
Jiadai Liu, Yong Chen
AJP Endocrinology and Metabolism (2024) Vol. 327, Iss. 3, pp. E371-E383
Closed Access

FFAR4 activation inhibits lung adenocarcinoma via blocking respiratory chain complex assembly associated mitochondrial metabolism
Zhe Wang, Jinyou Li, LongFei Wang, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access

The CLCF1-CNTFR axis drives an immunosuppressive tumor microenvironment and blockade enhances the effects of established cancer therapies
E. Alejandro Sweet‐Cordero, Kieren D. Marini, Emma C. Champion, et al.
Research Square (Research Square) (2024)
Open Access

Juglone triggers apoptosis of non-small cell lung cancer through the reactive oxygen species -mediated PI3K/Akt pathway
Jian Zhong, Yongzhi Hua, Shuting Zou, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0299921-e0299921
Open Access

Detection of CLCF1 protein expression by flow cytometry
Véronique Laplante, Marine Rousseau, Félix Lombard‐Vadnais, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

MIS18A upregulation promotes cell viability, migration and tumor immune evasion in lung adenocarcinoma
Yongjie Zhu, Zihao Li, Zuotao Wu, et al.
Oncology Letters (2024) Vol. 28, Iss. 2
Open Access

DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways
Yasmeen Fleifil, Ruhi Gulati, Katherine M. Jennings, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 83-83
Open Access

Characterization of Infiltrating Immune Cells and Secretory or Membrane-Associated Proteins in KRAS Lung Adenocarcinoma
Yunyi Bian, Guoshu Bi, Guangyao Shan, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-12
Open Access | Times Cited: 1

Systematic Analysis of the Prognostic Significance and Roles of the Integrin Alpha Family in Non-Small Cell Lung Cancers
Yu Huang, Dongming Guo, Shi Bu, et al.
Advances in Therapy (2023) Vol. 40, Iss. 5, pp. 2186-2204
Closed Access | Times Cited: 1

An engineered interleukin‐11 decoy cytokine inhibits receptor signaling and proliferation in lung adenocarcinoma
Brianna J. McIntosh, Griffin G. Hartmann, Sean A. Yamada‐Hunter, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 6
Open Access | Times Cited: 1

Molecular Signature of Neuroinflammation Induced in Cytokine-Stimulated Human Cortical Spheroids
Kim M. A. De Kleijn, Kirsten R. Straasheijm, Wieteke A. Zuure, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1025-1025
Open Access | Times Cited: 2

P-Rex1 Signaling Hub in Lower Grade Glioma Patients, Found by In Silico Data Mining, Correlates With Reduced Survival and Augmented Immune Tumor Microenvironment
Yarely Mabell Beltrán‐Navarro, Guadalupe Reyes‐Cruz, José Vázquez‐Prado
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 2

Genetic predisposition to lung adenocarcinoma outcome is a feature already present in patients' noninvolved lung tissue
Francesca Minnai, Sara Noci, Marco Chierici, et al.
Cancer Science (2022) Vol. 114, Iss. 1, pp. 281-294
Open Access | Times Cited: 1

Scroll to top